ARTBIO Announces Appointment of Nick Pullen, Ph.D., as Chief Scientific Officer

Management expansion strengthens capabilities in developing new class of alpha radioligand therapies

Related Keywords

Norway ,United Kingdom ,Cambridge ,Cambridgeshire ,London ,City Of ,Switzerland ,Oslo ,Nick Pullen ,Emanuele Ostuni ,Pfizer ,Linkedin ,Integrative Sciences At Celgene ,Twitter ,University Of Oslo ,Prnewswire Artbio Inc ,Friedrich Miescher Institute In Basel ,University Of Southampton ,Head Of Research At Jnana Therapeutics ,Chief Scientific ,Chief Executive Officer ,Senior Vice President ,Vice President ,Integrative Sciences ,Friedrich Miescher Institute ,Region ,